Chaudhari Nayana, Prakash Nilima, Pradeep G L, Mahajan Aarti, Lunawat Snehal, Salunkhe Vaibhavi
Department of Oral and Maxillofacial Pathology, MGV'S K.B.H. Dental College and Hospital, Nashik, Maharashtra, India.
Department of Oral and Maxillofacial Pathology, SMBT College and Hospital Research Center, Ghoti, Maharashtra, India.
J Oral Maxillofac Pathol. 2020 Sep-Dec;24(3):577. doi: 10.4103/jomfp.JOMFP_109_20. Epub 2021 Jan 9.
Macrophages account for 30%-50% of the total inflammatory cell population of ''tumor microenvironment'' that plays an important role in cancer metastasis. M2 macrophages are designated as tumor-associated macrophages (TAMs). They are known to orchestrate all the stages of tumor progression. CD163 is TAMs-M2-specific marker.
The aim of the study was to evaluate the role of TAMs using CD163 in different histological grades of oral squamous cell carcinoma (OSCC).
Expression of CD 163 was investigated in 30 histopthologically diagnosed cases of OSCC.
Two sections of 4-μ thickness were stained with hematoxylin and eosin, CD163 (Cell Marque, USA). The expression of TAMs with CD163-positive cells was done by counting the number of macrophages in three high-power fields (×400), and the mean number of macrophages per HPF was evaluated.
The statistical analysis was performed using Statistical Software SPSS version 20.0.
CD163 TAMs score increasing in higher tumor, node, metastasis stages with significant positive correlation.
With higher histological grades, CD163 TAMs score increased. Thus, TAMs may be considered as an independent factor for determining the progression of the tumor. The immunotherapeutic approaches to control M2 TAM numbers could protect against progression to malignancy.
巨噬细胞占“肿瘤微环境”中炎性细胞总数的30%-50%,在癌症转移中起重要作用。M2巨噬细胞被指定为肿瘤相关巨噬细胞(TAMs)。已知它们在肿瘤进展的所有阶段发挥协调作用。CD163是TAMs-M2特异性标志物。
本研究的目的是评估使用CD163的TAMs在不同组织学分级的口腔鳞状细胞癌(OSCC)中的作用。
在30例经组织病理学诊断的OSCC病例中研究CD163的表达。
取4μm厚的两片组织切片,用苏木精和伊红、CD163(美国Cell Marque公司)染色。通过计数三个高倍视野(×400)中的巨噬细胞数量来确定CD163阳性细胞的TAMs表达情况,并评估每个高倍视野中巨噬细胞的平均数量。
使用统计软件SPSS 20.0进行统计分析。
CD163 TAMs评分在肿瘤、淋巴结、转移分期较高时增加,具有显著正相关。
随着组织学分级升高,CD163 TAMs评分增加。因此,TAMs可被视为决定肿瘤进展的独立因素。控制M2 TAM数量的免疫治疗方法可预防肿瘤进展为恶性肿瘤。